Francisco Fraga Biography and Net Worth

EVP of McKesson

Francisco Fraga is Executive Vice President, Chief Information Officer and Chief Technology Officer for McKesson Corporation. As a member of the Executive Operating Team, Francisco leads McKesson’s technology initiatives, cybersecurity and guides the company’s overall technology strategy.

Francisco joined McKesson in 2021 as Senior Vice President and Chief Information Officer for McKesson’s US Pharmaceutical business, where he was responsible for defining and delivering the IT strategy to enable the key business imperatives of the company’s US Pharmaceutical Distribution and Oncology businesses. Prior to McKesson, Francisco was the Chief Technology and Information Officer at the Campbell Soup Company, where he had ownership for the enterprise IT strategy, focusing on creating value via technology-enabled business transformation in support of Campbell’s strategic objectives, while ensuring business continuity with IT operational excellence, governance, information security and enablement of M&A. Francisco also worked at Procter and Gamble for 22 years, having served in a variety of roles, including Chief Information Officer for the Feminine Care Business Unit and as global Chief Technology Officer.

Francisco holds a bachelor’s degree in computer engineering from Simon Bolivar University in his native home country of Venezuela.

What is Francisco Fraga's net worth?: The estimated net worth of Francisco Fraga is at least $5.49 million as of October 15th, 2026. Fraga owns 5,423 shares of McKesson stock worth more than $5,488,217 as of October 19th. This net worth evaluation does not reflect any other assets that Fraga may own. Learn More about Francisco Fraga's net worth.
How do I contact Francisco Fraga?: The corporate mailing address for Fraga and other McKesson executives is 6555 State Highway 161, Irving, TX, 75039. McKesson can also be reached via phone at (972) 446-4800 and via email at [email protected]. Learn More on Francisco Fraga's contact information.
Has Francisco Fraga been buying or selling shares of McKesson?: Within the last three months, Francisco Fraga has sold $796,640.00 in McKesson stock. Most recently, Francisco Fraga sold 800 shares of the business's stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $995.80, for a transaction totalling $796,640.00. Following the completion of the sale, the executive vice president now directly owns 5,423 shares of the company's stock, valued at $5,400,223.40. Learn More on Francisco Fraga's trading history.
Who are McKesson's active insiders?: McKesson's insider roster includes Nancy Avila (EVP), James Beer (CFO), Kevin Emerson (CAO), Tracy Faber (EVP), Nancy Flores (EVP), Francisco Fraga (EVP), John Hammergren (Chairman), B Jr (CAO), Marie Knowles (Director), Erin Lampert (SVP), Michele Lau (EVP), Bradley Lerman (Director), Maria Martinez (Director), Sundeep Reddy (SVP), Thomas Rodgers (EVP), Susan Salka (Director), Lori Schechter (EVP), LeAnn Smith (EVP), Brian Tyler (CEO), Brian Tyler (CEO), and Britt Vitalone (CFO). Learn More on McKesson's active insiders.
Are insiders buying or selling shares of McKesson?: During the last twelve months, insiders at the sold shares 17 times. They sold a total of 34,157 shares worth more than $27,453,513.98. The most recent insider tranaction occured on October, 15th when EVP Francisco Fraga sold 800 shares worth more than $796,640.00. Insiders at McKesson own 0.1% of the company. Learn More about insider trades at McKesson.
Information on this page was last updated on 10/15/2026.

Francisco Fraga Insider Trading History at McKesson

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
10/15/2026	Sell	800	$995.80	$796,640.00	5,423

Francisco Fraga Buying and Selling Activity at McKesson

McKesson Company Overview

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Today's Range

Now: $1,012.03

$977.89

$1,012.58

50 Day Range

MA: $900.34

$841.21

$1,012.03

2 Week Range

Now: $1,012.03

$723.68

$1,014.99

Volume

757,127 shs

Average Volume

929,776 shs

Market Capitalization

$117.99 billion

P/E Ratio

27.08

Dividend Yield

0.37%

Beta

0.3